Forecast: Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods in Germany

From 2024 to 2028, Germany's healthcare expenditure on pharmaceuticals and medical non-durable goods is forecasted to grow marginally from 1.8% to 1.85% of GDP. This represents a steady, albeit slow, increase with a Compound Annual Growth Rate (CAGR) of approximately 0.68% over these years. The year-on-year growth is quite restrained, indicating a stable yet unaccelerated trend in expenditure.

Future trends to watch for include:

• Potential impacts of healthcare policy changes on spending allocation.
• Technological advancements impacting pharmaceutical costs.
• Economic fluctuations that may alter public and private healthcare funding.
• Demographic changes, particularly an aging population driving demand for pharmaceuticals.